234 related articles for article (PubMed ID: 16565725)
1. Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activity.
Dennis RJ; Taylor EJ; Macauley MS; Stubbs KA; Turkenburg JP; Hart SJ; Black GN; Vocadlo DJ; Davies GJ
Nat Struct Mol Biol; 2006 Apr; 13(4):365-71. PubMed ID: 16565725
[TBL] [Abstract][Full Text] [Related]
2. Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants.
Cetinbaş N; Macauley MS; Stubbs KA; Drapala R; Vocadlo DJ
Biochemistry; 2006 Mar; 45(11):3835-44. PubMed ID: 16533067
[TBL] [Abstract][Full Text] [Related]
3. The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity.
Lee TN; Alborn WE; Knierman MD; Konrad RJ
Biochem Pharmacol; 2006 Sep; 72(6):710-8. PubMed ID: 16844097
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate.
Kim EJ; Kang DO; Love DC; Hanover JA
Carbohydr Res; 2006 Jun; 341(8):971-82. PubMed ID: 16584714
[TBL] [Abstract][Full Text] [Related]
5. Location and characterization of the O-GlcNAcase active site.
Toleman C; Paterson AJ; Kudlow JE
Biochim Biophys Acta; 2006 May; 1760(5):829-39. PubMed ID: 16517082
[TBL] [Abstract][Full Text] [Related]
6. Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog.
Toleman C; Paterson AJ; Shin R; Kudlow JE
Biochem Biophys Res Commun; 2006 Feb; 340(2):526-34. PubMed ID: 16376298
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
Rao FV; Dorfmueller HC; Villa F; Allwood M; Eggleston IM; van Aalten DM
EMBO J; 2006 Apr; 25(7):1569-78. PubMed ID: 16541109
[TBL] [Abstract][Full Text] [Related]
8. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.
Wells L; Gao Y; Mahoney JA; Vosseller K; Chen C; Rosen A; Hart GW
J Biol Chem; 2002 Jan; 277(3):1755-61. PubMed ID: 11788610
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities.
Toleman C; Paterson AJ; Whisenhunt TR; Kudlow JE
J Biol Chem; 2004 Dec; 279(51):53665-73. PubMed ID: 15485860
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
[TBL] [Abstract][Full Text] [Related]
11. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates.
Lazarus BD; Love DC; Hanover JA
Glycobiology; 2006 May; 16(5):415-21. PubMed ID: 16434389
[TBL] [Abstract][Full Text] [Related]
12. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
Whelan SA; Hart GW
Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
[TBL] [Abstract][Full Text] [Related]
13. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells.
Hanover JA; Lai Z; Lee G; Lubas WA; Sato SM
Arch Biochem Biophys; 1999 Feb; 362(1):38-45. PubMed ID: 9917327
[TBL] [Abstract][Full Text] [Related]
14. Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain.
Rao FV; Schüttelkopf AW; Dorfmueller HC; Ferenbach AT; Navratilova I; van Aalten DM
Open Biol; 2013 Oct; 3(10):130021. PubMed ID: 24088714
[TBL] [Abstract][Full Text] [Related]
15. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
Kim EJ; Perreira M; Thomas CJ; Hanover JA
J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
[TBL] [Abstract][Full Text] [Related]
16. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.
Gao Y; Wells L; Comer FI; Parker GJ; Hart GW
J Biol Chem; 2001 Mar; 276(13):9838-45. PubMed ID: 11148210
[TBL] [Abstract][Full Text] [Related]
17. Probing synergy between two catalytic strategies in the glycoside hydrolase O-GlcNAcase using multiple linear free energy relationships.
Greig IR; Macauley MS; Williams IH; Vocadlo DJ
J Am Chem Soc; 2009 Sep; 131(37):13415-22. PubMed ID: 19715310
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcase.
Macauley MS; Vocadlo DJ
Carbohydr Res; 2009 Jun; 344(9):1079-84. PubMed ID: 19423084
[TBL] [Abstract][Full Text] [Related]
19. Enzyme molecular mechanism as a starting point to design new inhibitors: a theoretical study of O-GlcNAcase.
Lameira J; Alves CN; Tuñón I; Martí S; Moliner V
J Phys Chem B; 2011 May; 115(20):6764-75. PubMed ID: 21542586
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of a β-N-acetylglucosaminidase (BmFDL) from silkworm Bombyx mori.
Nomura T; Ikeda M; Ishiyama S; Mita K; Tamura T; Okada T; Fujiyama K; Usami A
J Biosci Bioeng; 2010 Oct; 110(4):386-91. PubMed ID: 20547376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
